Non-Invasive Plasma Treatment for Cervical Infections: Targeting High- and Low-Risk HPV Variants
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorUniversity Hospital Tuebingen
About this trial
This is a prospective, single-center, observational proof-of-principle clinical trial at the Department of Women's Health of the University Hospital Tübingen.
Eligibility criteria
Qualifiers
Inclusion criteria for NIPP treatment
Age ≥ 18 years
mRNA or DNA-based virus detection by smear (also external findings)
Clearly visible transformation zone of the cervix and margins of the lesions corresponding to T1/T2
Disqualifiers
Transformation zone not fully visible
Evidence of invasive disease
Serious cardiovascular diseases
Trial design
Treatments tested in this trial
- Cold physical Plasma
- Control group
Treatment groups
50 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov